참고문헌
- Aus G, Abbou CC, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol 2005;48:546-551 https://doi.org/10.1016/j.eururo.2005.06.001
- Aus G. Current status of HIFU and cryotherapy in prostate cancer--a review. Eur Urol 2006;50:927-934; discussion 934 https://doi.org/10.1016/j.eururo.2006.07.011
- Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007;51:381-387 https://doi.org/10.1016/j.eururo.2006.04.012
- Forsythe K, Blacksburg S, Stone N, Stock RG. Intensitymodulated radiotherapy causes fewer side effects than threedimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2012;83:630-635 https://doi.org/10.1016/j.ijrobp.2011.06.2013
- Orsi F, Arnone P, Chen W, Zhang L. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. J Cancer Res Ther 2010;6:414-420 https://doi.org/10.4103/0973-1482.77064
- Colombel M, Gelet A. Principles and results of high-intensity focused ultrasound for localized prostate cancer. Prostate Cancer Prostatic Dis 2004;7:289-294 https://doi.org/10.1038/sj.pcan.4500721
- Rebillard X, Gelet A, Davin JL, et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 2005;19:693-701 https://doi.org/10.1089/end.2005.19.693
- Gelet A, Chapelon JY, Poissonnier L, et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004;63:625-629 https://doi.org/10.1016/j.urology.2004.01.002
- Rouviere O, Lyonnet D, Raudrant A, et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 2001;40:265-274 https://doi.org/10.1159/000049786
- Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C. MR imaging of prostate after treatment with highintensity focused ultrasound. Radiology 2008;246:833-844 https://doi.org/10.1148/radiol.2463062080
- Kim CK, Park BK, Lee HM, Kim SS, Kim E. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 2008;190:1180-1186 https://doi.org/10.2214/AJR.07.2924
- Ben Cheikh A, Girouin N, Ryon-Taponnier P, et al. MR detection of local prostate cancer recurrence after transrectal highintensity focused US treatment: preliminary results. J Radiol 2008;89:571-577 https://doi.org/10.1016/S0221-0363(08)71483-5
- Punwani S, Emberton M, Walkden M, et al. Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease. Br J Radiol 2012;85:720-728 https://doi.org/10.1259/bjr/61380797
- Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-739 https://doi.org/10.1148/radiol.2353042205
- Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003;229:248-254 https://doi.org/10.1148/radiol.2291020200
- Futterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005;237:541-549 https://doi.org/10.1148/radiol.2372041724
- Kim JK, Hong SS, Choi YJ, et al. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging 2005;22:639-646 https://doi.org/10.1002/jmri.20431
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174 https://doi.org/10.2307/2529310
- Donahue KM, Weisskoff RM, Parmelee DJ, et al. Dynamic Gd- DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 1995;34:423-432 https://doi.org/10.1002/mrm.1910340320
- Isebaert S, Van den Bergh L, Haustermans K, et al. Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging 2012
- Ocak I, Bernardo M, Metzger G, et al. Dynamic contrastenhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 2007;189:849